Literature DB >> 24684899

Familial malignant mesothelioma: a population-based study in central Italy (1980-2012).

Valeria Ascoli1, Elisa Romeo2, Caterina Carnovale Scalzo2, Ilaria Cozzi2, Laura Ancona2, Fulvio Cavariani3, Anna Balestri3, Letizia Gasperini3, Francesco Forastiere2.   

Abstract

Malignant mesothelioma is a sporadic cancer linked to asbestos exposure. Its occurrence among blood relatives (familial mesothelioma) may point to genetic susceptibility or shared exposures. The burden of the familial disease is unknown. The aims of the study were to assess at population level the proportion of familial mesotheliomas among all mesotheliomas and to investigate the family history of cancer among relatives of mesothelioma cases. We actively searched familial clusters based on a mesothelioma registry from central Italy (5.5 million people, 10% of the Italian population) of the National Mesothelioma Register network (ReNaM) as well as a pathology-based archive. Among 997 incident mesotheliomas recorded in a 32-year-period (1980-2012), we detected 13 clusters and 34 familial cases, accounting for 3.4% of all mesotheliomas. The most common clusters where those with affected siblings and unaffected parents. Asbestos exposure was occupational (n=7 clusters), household (n=2), environmental (n=1), or not attributable for insufficient information (n=3). There were 25 additional cancers in nine families. Some were cancer sites for which there is sufficient evidence (lung and larynx) or limited evidence (stomach and colon) of causal association with asbestos. The results suggest potential genetic recessive effects in mesothelioma that interact with asbestos exposure, but it is not possible to estimate the specific proportion attributable to each of these components.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asbestos exposure; Family history; Italy; Lung cancer; Malignant mesothelioma

Mesh:

Substances:

Year:  2014        PMID: 24684899     DOI: 10.1016/j.canep.2014.02.014

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  4 in total

1.  Mesothelioma in Mongolia: case report.

Authors:  Naransukh Damiran; Khishigtogtokh Davaajav; Erdenechimeg Erdenebayar; Burmaa Gomboloi; Arthur L Frank
Journal:  Int J Occup Environ Health       Date:  2015-01-13

2.  Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks.

Authors:  Swaroop Kumar Pandey; Renen Machlof-Cohen; Manikandan Santhanam; Anna Shteinfer-Kuzmine; Varda Shoshan-Barmatz
Journal:  Biomolecules       Date:  2022-06-27

3.  An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation.

Authors:  Mitchell Cheung; Yuwaraj Kadariya; Jianming Pei; Jacqueline Talarchek; Francesco Facciolo; Paolo Visca; Luisella Righi; Ilaria Cozzi; Joseph R Testa; Valeria Ascoli
Journal:  Cancer Genet       Date:  2015-07-30

Review 4.  Amatuximab and novel agents targeting mesothelin for solid tumors.

Authors:  Paolo Baldo; Sara Cecco
Journal:  Onco Targets Ther       Date:  2017-11-08       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.